• Je něco špatně v tomto záznamu ?

Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners

J. Gemperle, R. Hexnerová, M. Lepšík, P. Tesina, M. Dibus, M. Novotný, J. Brábek, V. Veverka, D. Rosel,

. 2017 ; 7 (1) : 8057. [pub] 20170814

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19013095

CAS is a docking protein downstream of the proto-oncogene Src with a role in invasion and metastasis of cancer cells. The CAS SH3 domain is indispensable for CAS-mediated signaling, but structural aspects of CAS SH3 ligand binding and regulation are not well understood. Here, we identified the consensus CAS SH3 binding motif and structurally characterized the CAS SH3 domain in complex with ligand. We revealed the requirement for an uncommon centrally localized lysine residue at position +2 of CAS SH3 ligands and two rather dissimilar optional anchoring residues, leucine and arginine, at position +5. We further expanded the knowledge of CAS SH3 ligand binding regulation by manipulating tyrosine 12 phosphorylation and confirmed the negative role of this phosphorylation on CAS SH3 ligand binding. Finally, by exploiting the newly identified binding requirements of the CAS SH3 domain, we predicted and experimentally verified two novel CAS SH3 binding partners, DOK7 and GLIS2.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19013095
003      
CZ-PrNML
005      
20190405092904.0
007      
ta
008      
190405s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-017-08303-4 $2 doi
035    __
$a (PubMed)28808245
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Gemperle, Jakub $u Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, Prague, Czech Republic.
245    10
$a Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners / $c J. Gemperle, R. Hexnerová, M. Lepšík, P. Tesina, M. Dibus, M. Novotný, J. Brábek, V. Veverka, D. Rosel,
520    9_
$a CAS is a docking protein downstream of the proto-oncogene Src with a role in invasion and metastasis of cancer cells. The CAS SH3 domain is indispensable for CAS-mediated signaling, but structural aspects of CAS SH3 ligand binding and regulation are not well understood. Here, we identified the consensus CAS SH3 binding motif and structurally characterized the CAS SH3 domain in complex with ligand. We revealed the requirement for an uncommon centrally localized lysine residue at position +2 of CAS SH3 ligands and two rather dissimilar optional anchoring residues, leucine and arginine, at position +5. We further expanded the knowledge of CAS SH3 ligand binding regulation by manipulating tyrosine 12 phosphorylation and confirmed the negative role of this phosphorylation on CAS SH3 ligand binding. Finally, by exploiting the newly identified binding requirements of the CAS SH3 domain, we predicted and experimentally verified two novel CAS SH3 binding partners, DOK7 and GLIS2.
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a aminokyseliny $x metabolismus $7 D000596
650    _2
$a vazebná místa $x fyziologie $7 D001665
650    _2
$a substrátový protein asociovaný s Crk $x metabolismus $7 D050719
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    _2
$a fosforylace $x fyziologie $7 D010766
650    _2
$a vazba proteinů $x fyziologie $7 D011485
650    _2
$a signální transdukce $x fyziologie $7 D015398
650    _2
$a src homologní domény $x fyziologie $7 D018909
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hexnerová, Rozálie $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, Prague, Czech Republic.
700    1_
$a Lepšík, Martin $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, Prague, Czech Republic.
700    1_
$a Tesina, Petr $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, Prague, Czech Republic.
700    1_
$a Dibus, Michal $u Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, Prague, Czech Republic.
700    1_
$a Novotný, Marian $u Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, Prague, Czech Republic.
700    1_
$a Brábek, Jan $u Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, Prague, Czech Republic.
700    1_
$a Veverka, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, Prague, Czech Republic. veverka@uochb.cas.cz.
700    1_
$a Rosel, Daniel $u Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, Prague, Czech Republic. rosel@natur.cuni.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 8057
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28808245 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190405092913 $b ABA008
999    __
$a ok $b bmc $g 1392405 $s 1051400
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c 1 $d 8057 $e 20170814 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Možnosti archivace